J&J cements footprint in Italy with €580M in investments over the next 5 years

Johnson & Johnson Innovative Medicine (JJIM), formerly known as Janssen, is earmarking €580 million ($622 million) in investments in Italy over the next five years …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Nearly 60% of Healthcare Providers Experienced a Data Breach Since 2021

What You Should Know: Nearly 60% of healthcare providers experienced one or more security breaches and 45% experienced a data breach from an outside source

July 5, 2023

Travere halts Phase 3 inherited disease trial due to manufacturing scale-up issue

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 28, 2024

Gen Z Doesn’t Want to Answer Your Call: How Providers Can Customize Communications

John Zimmerer, VP of Vertical Marketing, Healthcare at Smart Communications Generation Z has never known a world without pervasive digital technology. From smartphones and social

October 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.